MENU
CLRB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cellectar Biosciences (CLRB) Earnings Date & Reports

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

CLRB is expected to report earnings to rise 167.86% to -18 cents per share on May 07

Cellectar Biosciences CLRB Stock Earnings Reports
Q1'25
Est.
$-0.19
Q4'24
Beat
by $0.28
Q3'24
Missed
by $0.07
Q2'24
Missed
by $0.02
Q1'24
Missed
by $0.21
The last earnings report on March 13 showed earnings per share of -7 cents, beating the estimate of -34 cents. With 412.76K shares outstanding, the current market capitalization sits at 13.92M.
View a ticker or compare two or three
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Campus Drive
Phone
+1 608 441-8120
Employees
20
Web
https://www.cellectar.com